D-0547-2026 Class II Ongoing
FDA drug recall D-0547-2026 was initiated by Ascend Laboratories, LLC on Apr 27, 2026 and is designated Class II. Reason for recall: Failed Dissolution Specifications The recall status is ongoing. Affected quantity: 17,304 100-count bottles.
Recall details
- Product Type
- Drugs
- Report Date
- May 20, 2026
- Initiation Date
- Apr 27, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 17,304 100-count bottles
Product description
Ascend Laboratories, LLC, Metoprolol Succinate Extended-Release Tablets, USP, 25 mg* Rx Only, Manufactured by: Alkem Laboratories Ltd., India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-590-01.
Reason for recall
Failed Dissolution Specifications
Distribution pattern
U.S. Nationwide
Code information
Lot # 25140859; Exp. Date: Jan 2027
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0547-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026